Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
University of Washington
Mayo Clinic
National Cancer Institute (NCI)
Wake Forest University Health Sciences
Fox Chase Cancer Center
Mayo Clinic
M.D. Anderson Cancer Center
Washington University School of Medicine
University of Virginia
Yale University
Virginia Commonwealth University
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)